Shay Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,000
Closed -$517K 560
2026
Q1
$517K Buy
8,000
+3,000
+60% +$211K 0.04% 267
2025
Q4
$337K Buy
+5,000
New +$336K 0.03% 342
2025
Q3
Sell
-30,000
Closed -$1.56M 453
2025
Q2
$1.56M Buy
30,000
+23,958
+397% +$1.36M 0.18% 87
2025
Q1
$386K Buy
6,042
+1,542
+34% +$89.6K 0.06% 174
2024
Q4
$215K Buy
+4,500
New +$231K 0.03% 250

Other funds holding HALO

Shay Capital's HALO Position: Q2 2026 in Review

Shay Capital sold out of Halozyme (HALO) in Q2 2026, closing a stake of 8,000 shares — an estimated $517K sold.

Shay Capital first reported a position in HALO in Q4 2024 and held it in 5 quarters. The position peaked at $1.56M in Q2 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Shay Capital reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Shay Capital sold 8,000 Halozyme shares in Q2 2026, an estimated $517K.
  • Shay Capital first reported a position in Halozyme in Q4 2024 and held it in 5 quarters.
  • Shay Capital's Halozyme position peaked at $1.56M in Q2 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.